By Dr Frank Po-Yen Lin

Journal articles

Lin FP; Stephen A; Polasek TM; Tsafnat G; Doogue MP, 2011, 'BICEPP: an example-based statistical text mining method for predicting the binary characteristics of drugs', BMC bioinformatics, 12, pp. 112

Lin FP; Sintchenko V; Kong F; Gilbert GL; Coiera E, 2009, 'Commonly used molecular epidemiology markers of Streptococcus agalactiae do not appear to predict virulence', Pathology, 41, pp. 576 - 581

Lin FP; Coiera E; Lan R; Sintchenko V, 2009, 'In silico prioritisation of candidate genes for prokaryotic gene function discovery: an application of phylogenetic profiles.', BMC bioinformatics, 10, pp. 86 - 86, http://dx.doi.org/10.1186/1471-2105-10-86

Conference Papers

Lin FPY; Tan ABT, 2018, 'A Signal-Seeking Text Mining Analysis for Identifying Clinical Factors Associated with Treatment Benefit from Pazopanib or Sunitinib in Metastatic Clear Cell Renal Cell Carcinoma', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437670700033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Teng C; Shahid N; Lin FPY; Moylan E, 2016, 'FEASIBILITY OF A RESEARCH PROTOCOL FOR STUDYING PATTERNS OF INVESTIGATION AND TREATMENT FOR BONE COMPLICATIONS IN PATIENTS TREATED WITH AROMATASE INHIBITORS FOR EARLY BREAST CANCER', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 132 - 132, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lin FP; Polasek TM; Stephen A; Tsafnat G; Doogue MP; Anthony S, 2010, 'BICEPP: a computational text mining method for predicting binary characteristics of drugs', in BMC Bioinformatics, Springer Nature, Melbourne, Australia, pp. 40 - 40, presented at ASCEPT Annual Scientific meeting, Melbourne, Australia, 28 November 2010 - 01 December 2010, http://dx.doi.org/10.1186/1471-2105-12-112

Lin FP; Coiera E, 2010, 'A clinical workflow model for facilitating the design and evaluation of computerised clinical decision support systems', in 18th Annual Health Informatics Conference, Health Informatics Society of Australia, Mebourne, pp. 61 - 65, presented at HIC2010: Informing the business of healthcare, Melbourne, 24 August 2010 - 26 August 2010, http://search.informit.com.au/documentSummary;dn=429770463684403;res=IELHEA

Lin FP, 2009, 'Towards Personalised Pharmacotherapy: A Perspective from Biomedical Informatics', in HIC 2009: Proceedings; Frontiers of Health Informatics - Redefining Healthcare, National Convention Centre Canberra, 19-21 August 2009., Informit (RMIT Publishing), Melbourne, Australia, pp. 57 - 62, presented at HIC2009 Frontiers of Health Informatics - Redefining Healthcare, Canberra, 19 August 2009 - 21 August 2009, http://search.informit.com.au/documentSummary;dn=497482681236702;res=IELHSS

Lin FP, 2007, 'The role of data mining in clinical predictive medicine: a narrative review.', in HIC 2006 Bridging the Digital Divide: Clinician, consumer and computer, Melbourne, pp. 169 - 174, presented at HIC 2006 Bridging the Digital Divide: Clinician, consumer and computer, Melbourne, 31 July 2007 - 02 August 2007, http://training.informit.com.au/documentSummary;dn=951771578616360;res=IELHSS

Conference Posters

Lin FP, 2011, 'Uncovering genes associated with human infections in pathogenic bacteria: a novel integrative analysis linking genome, bibliome, and diseasome', San Francisco, pp. 131, presented at AMIA Translational Bioinformatics Summit, San Francisco, 07 March 2011 - 09 March 2011

Conference Abstracts

Zaheed M; Grady JP; Murrow B; Douglas B; Carpenter E; Mckay S; Liang S; Taylor N; Lin FP-Y; Goldstein D; Tucker K; Thomas DM; Ballinger ML, 2024, 'Translating potential germline findings from tumour profiling into routine clinical care.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, JAPAN, Yokohama, Vol. 42, pp. 105 - 105, presented at ASCO Breakthrough: A Global Summit for Oncology Innovators, JAPAN, Yokohama, 08 August 2024 - 10 August 2024, http://dx.doi.org/10.1200/JCO.2024.42.23_suppl.105

Lin FP-Y; Grady JP; Napier CE; Callow M; Thavaneswaran S; Huang ML; Zaheed M; Kansara M; Sebastian L; Ballinger ML; Simes J; Thomas DM, 2024, 'Impact of artificial intelligence (AI) decision support on clinical trial participation: A before-after implementation study on a nationwide molecular tumor board.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 42, pp. 1557 - 1557, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.1557

Lin FP; Mersiades A; Lee J; Xu W; Chinchen S; Charakidis M; Thavaneswaran S; Hughes BGM; Underhill CR; Takhar HS; Harrup R; Nagrial A; Millward M; Desai J; Espinoza D; Lee CK; Solomon BJ; Simes J; Pavlakis N; Thomas D, 2024, '623P Phase II trial of vemurafenib (VEM) and cobimetinib (COB) in BRAF V600-mutated solid tumours and first-line (1L) non-small cell lung cancer (NSCLC): Australian molecular screening and therapeutics (MoST) substudy 12', in Annals of Oncology, Elsevier BV, Vol. 35, pp. S498 - S498, http://dx.doi.org/10.1016/j.annonc.2024.08.690

Kong BY; Lin FP-Y; Espinoza D; Thavaneswaran S; Meniawy T; Desai J; Harrup R; Selva-Nayagam S; Charakidis M; Cuff K; Sebastian L; Lee CK; Chinchen S; Thomas DM; Ballinger ML; Simes J; Goldstein D, 2024, '636P Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplification: A molecular screening and therapeutics (MoST) program substudy', in Annals of Oncology, Elsevier BV, Vol. 35, pp. S505 - S505, http://dx.doi.org/10.1016/j.annonc.2024.08.703

Lin FP-Y; Thavaneswaran S; Grady JP; Napier CE; Kansara M; Sebastian L; Kee D; Oakes SR; Blackburn J; Scott HS; Glover A; Fox SB; Goldstein D; Leo P; Amanuel B; Desai J; Lee CK; Ballinger ML; Simes J; Thomas DM, 2022, 'Molecular therapy selection in treatment-refractory advanced cancers: A retrospective cohort study determining the utility of TOPOGRAPH knowledge base.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. 3073 - 3073, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.3073

Lin FP; Salih OSM; Epstein RJ, 2018, 'EXPLORATORY ANALYSIS OF CLINICAL PROGNOSTIC FACTORS IN PATIENTS WITH ADVANCED CANCER USING COMPUTATIONAL TEXT MINING OF ROUTINE DIGITISED ONCOLOGY CORRESPONDENCE', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 48, pp. 8 - 8, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431995500009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lin FP-Y; Martin C; Kocbek S; Joshua AM; Dear RF-G; Lim E; Chantrill LA; Chin VT; Epstein RJ, 2017, 'Identifying determinants of quality of life in patients undergoing systemic therapy for solid tumors.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 35, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.6596

Lin FP-Y; Groza T; Kocbek S; Antezana E; Epstein RJ, 2017, 'The Cancer Care Treatment Outcomes Ontology (CCTO): A computable ontology for profiling treatment outcomes of patients with solid tumors.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 35, presented at 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e18137

Lin FPY; Pokorny A; Teng C; Dear R; Epstein RJ, 2016, 'AN ALTERNATING DECISION TREE MODEL FOR PREDICTING MULTIDISCIPLINARY TEAM MEETING DECISION ABOUT ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER PATIENTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 59 - 59

Preprints

Walpole I; Zaman FY; Zhao P; Marshall VM; Lin F; Thomas DM; Shackleton M; Antolin AA; Ameratunga M, 2023, Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases, http://dx.doi.org/10.1101/2023.07.01.547311

Thavaneswaran S; Lin FP; Kansara M; Grady JP; Espinoza D; Joshua AM; Grimison P; Craft P; Cosman R; Lee C; Harwood K; Chinchen S; Corpuz T; Ballinger M; Sebastian L; Simes J; Thomas D, 2022, A signal-seeking Phase II trial of Durvalumab and Tremelimumab Focused on Advanced, Rare and Less Common Cancers, http://dx.doi.org/10.1101/2022.06.30.22277092

Thavaneswaran S; Sebastian L; Kansara M; Ballinger M; Espinoza D; Lin F; Lee C; Sjoquist K; Grady J; Cowley M; Joshua A; Qiu M; Oakes S; Simes J; Thomas D, 2021, A Signal-seeking Phase Iia Trial of Palbociclib in Advanced Cancers With Cell Cycle Pathway Alterations – A Substudy of the Molecular Screening and Therapeutics (Most) Program, http://dx.doi.org/10.21203/rs.3.rs-254137/v1

Lin FPY, 2020, Design and implementation of an intelligent framework for supporting evidence-based treatment recommendations in precision oncology, http://dx.doi.org/10.1101/2020.11.15.383448

Lin FPY; Salih OSM; Scott N; Jameson MB; Epstein RJ, 2020, Repurposing digitised clinical narratives to discover prognostic factors and predict survival in patients with advanced cancer, http://dx.doi.org/10.1101/2020.10.28.20214627

Back to profile page